Plus Therapeutics Inc (PSTV)
1.34
-0.01
(-0.74%)
USD |
NASDAQ |
Nov 04, 13:04
Plus Therapeutics Enterprise Value: 2.817M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.817M |
| October 31, 2024 | 2.611M |
| October 30, 2024 | 2.640M |
| October 29, 2024 | 2.817M |
| October 28, 2024 | 2.792M |
| October 25, 2024 | 2.817M |
| October 24, 2024 | 2.818M |
| October 23, 2024 | 2.994M |
| October 22, 2024 | 3.010M |
| October 21, 2024 | 3.112M |
| October 18, 2024 | 3.348M |
| October 17, 2024 | 3.171M |
| October 16, 2024 | 3.289M |
| October 15, 2024 | 3.171M |
| October 14, 2024 | 2.640M |
| October 11, 2024 | 2.935M |
| October 10, 2024 | 2.522M |
| October 09, 2024 | 2.876M |
| October 08, 2024 | 2.817M |
| October 07, 2024 | 3.171M |
| October 04, 2024 | 2.522M |
| October 03, 2024 | 2.541M |
| October 02, 2024 | 3.171M |
| October 01, 2024 | 2.581M |
| September 30, 2024 | 3.466M |
| Date | Value |
|---|---|
| September 27, 2024 | 5.765M |
| September 26, 2024 | 3.937M |
| September 25, 2024 | 3.937M |
| September 24, 2024 | 3.878M |
| September 23, 2024 | 4.232M |
| September 20, 2024 | 4.527M |
| September 19, 2024 | 4.291M |
| September 18, 2024 | 4.409M |
| September 17, 2024 | 4.232M |
| September 16, 2024 | 3.760M |
| September 13, 2024 | 3.584M |
| September 12, 2024 | 3.289M |
| September 11, 2024 | 2.817M |
| September 10, 2024 | 2.286M |
| September 09, 2024 | 2.050M |
| September 06, 2024 | 3.171M |
| September 05, 2024 | 2.964M |
| September 04, 2024 | 3.318M |
| September 03, 2024 | 3.760M |
| August 30, 2024 | 3.289M |
| August 29, 2024 | 3.230M |
| August 28, 2024 | 3.289M |
| August 27, 2024 | 3.479M |
| August 26, 2024 | 3.407M |
| August 23, 2024 | 3.377M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.711M
Minimum
May 11 2022
26.22M
Maximum
Feb 24 2021
5.850M
Average
3.796M
Median
Jun 16 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| InfuSystems Holdings Inc | 170.22M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.94M |
| Total Expenses (Quarterly) | 3.697M |
| EPS Diluted (Quarterly) | -0.71 |
| Earnings Yield | -235.8% |
| Normalized Earnings Yield | -233.35 |